Literature DB >> 17854465

Hepatic iron accumulation may be associated with insulin resistance in patients with chronic hepatitis C.

Yoshio Sumida1, Kazuyuki Kanemasa, Kohei Fukumoto, Naohisa Yoshida, Kyoko Sakai.   

Abstract

BACKGROUND/AIM: Insulin resistance and hepatic iron overload are frequently demonstrated in hepatitis C virus (HCV)-related liver diseases. We investigated the relationship between insulin resistance and hepatic iron deposition in patients with chronic HCV infection.
METHODS: Insulin resistance was evaluated using the homeostasis model assessments for insulin resistance (HOMA-IR) in 56 non-diabetic non-obese patients with biopsy proven chronic hepatitis C. The relationship between insulin resistance and serum ferritin levels or the grade of hepatic iron deposition was assessed.
RESULTS: The levels of plasma immunoreactive insulin (IRI) and HOMA-IR were significantly correlated with serum ferritin levels and the grade of hepatic iron deposition (P = 0.003).Although IRI and HOMA-IR increased in parallel with the development of hepatic fibrosis, insulin resistance (HOMA-IR > 2) was observed in 11 (26.2%) of 42 patients even without severe fibrosis (F0-2). Among patients without severe fibrosis, IRI and HOMA-IR were significantly higher in patients with iron deposits than in those without iron deposits.
CONCLUSION: Hepatic iron overload may be associated with insulin resistance in patients with chronic hepatitis C, especially in patients with mild to moderate fibrosis.

Entities:  

Year:  2007        PMID: 17854465     DOI: 10.1111/j.1872-034X.2007.00152.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  7 in total

1.  Successful antiviral therapy is associated with a decrease of serum prohepcidin in chronic hepatitis C.

Authors:  Jerzy Jaroszewicz; Magdalena Rogalska; Iwona Flisiak; Robert Flisiak
Journal:  World J Gastroenterol       Date:  2010-04-14       Impact factor: 5.742

Review 2.  Hepatitis C virus induced insulin resistance impairs response to anti viral therapy.

Authors:  Abdel-Rahman El-Zayadi; Mahmoud Anis
Journal:  World J Gastroenterol       Date:  2012-01-21       Impact factor: 5.742

3.  Insulin sensitivity and variability in hepatitis C virus infection using direct measurement.

Authors:  Nizar A Mukhtar; Peter Bacchetti; Claudia E Ayala; Jennifer Melgar; Spencer Christensen; Jacquelyn J Maher; Mandana Khalili
Journal:  Dig Dis Sci       Date:  2012-10-21       Impact factor: 3.199

4.  Serum or plasma ferritin concentration as an index of iron deficiency and overload.

Authors:  Maria Nieves Garcia-Casal; Sant-Rayn Pasricha; Ricardo X Martinez; Lucero Lopez-Perez; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24

5.  Evolution of ferritin levels in hepatitis C patients treated with antivirals.

Authors:  Ming-Ling Chang; Jing-Hong Hu; Ching-Hao Yen; Kuan-Hsing Chen; Chia-Jung Kuo; Ming-Shyan Lin; Cheng-Han Lee; Shiang-Chi Chen; Rong-Nan Chien
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

6.  Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?

Authors:  Giovanni Tarantino; Paolo Conca; Antonio Riccio; Marianna Tarantino; Matteo N Di Minno; Domenico Chianese; Fabrizio Pasanisi; Franco Contaldo; Francesco Scopacasa; Domenico Capone
Journal:  J Transl Med       Date:  2008-11-27       Impact factor: 5.531

Review 7.  HCV and oxidative stress in the liver.

Authors:  Alexander V Ivanov; Birke Bartosch; Olga A Smirnova; Maria G Isaguliants; Sergey N Kochetkov
Journal:  Viruses       Date:  2013-01-28       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.